HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.

Abstract
Protein tyrosine kinase 6 (PTK6) is a non-receptor tyrosine kinase expressed in epithelial cancers. Disruption of Ptk6 decreases azoxymethane-induced colon tumorigenesis in mice by preventing signal transducer and activator of transcription 3 activation. Relocalization of PTK6 in prostate cancers contributes to increased growth. Although not expressed in normal breast or ovary, PTK6 promotes anchorage-independent survival of breast and ovarian tumor cells. We identified several potential PTK6 substrates in the human SW620 colon cancer cell line using mass spectrometry, including FAK (focal adhesion kinase). We show that FAK is a direct substrate of PTK6 in vitro and in vivo. Expression of membrane-targeted active PTK6 (Palm-PTK6-YF) induces constitutive activation of FAK and cell morphology changes, which are independent of SRC family kinases in Src-/-, Yes-/-, Fyn-/- (SYF) mouse embryonic fibroblasts (MEFs). Palm-PTK6-YF expressing SYF cells are transformed and overcome contact inhibition, form colonies in transformation assays, proliferate in suspension and form tumors in a xenograft model. Expression of FAK and Palm-PTK6-YF in Fak-/- MEFs synergistically activates AKT and protects cells against anoikis. However, expression of Palm-PTK6-YF in Akt1/2-/- MEFs fails to protect cells from anoikis, indicating AKT is critical in PTK6 and FAK-mediated survival signaling. In a conditional Pten knockout murine prostate cancer model, we identify prostate epithelial cells with enhanced activation of endogenous PTK6 and FAK at the plasma membrane. Knockdown of PTK6 in the PC3 human prostate cancer cell line disrupts FAK and AKT activation and promotes anoikis, which can be rescued by exogenous expression of FAK. Our data reveal important roles for a PTK6-FAK-AKT signaling axis in promoting anchorage-independent cell survival.
AuthorsY Zheng, J Gierut, Z Wang, J Miao, J M Asara, A L Tyner
JournalOncogene (Oncogene) Vol. 32 Issue 36 Pg. 4304-12 (Sep 05 2013) ISSN: 1476-5594 [Electronic] England
PMID23027128 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Neoplasm Proteins
  • Protein-Tyrosine Kinases
  • Focal Adhesion Protein-Tyrosine Kinases
  • PTK6 protein, human
  • Ptk6 protein, mouse
  • src-Family Kinases
  • Proto-Oncogene Proteins c-akt
Topics
  • Animals
  • Anoikis (genetics)
  • Cell Line
  • Cell Transformation, Neoplastic (genetics, metabolism)
  • Enzyme Activation
  • Fibroblasts (metabolism, pathology)
  • Focal Adhesion Protein-Tyrosine Kinases (metabolism)
  • Gene Knockdown Techniques
  • Humans
  • Male
  • Mice
  • Neoplasm Proteins (genetics, metabolism)
  • Phosphorylation
  • Prostatic Neoplasms (genetics, metabolism)
  • Protein-Tyrosine Kinases (genetics, metabolism)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Signal Transduction
  • Substrate Specificity
  • src-Family Kinases (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: